SlideShare a Scribd company logo
CENTER FOR PHYSIOTHERAPY AND REHABILITATION
SCIENCE
JAMIA MILLIA ISLAMIA
By Qurat ul aein
19mpc005
MPTcardiorespiratory
Exercise in primary prevention
of coronary arteries disease
• The first scientific evidence regarding the beneficial effects of work associated exercise training
(ET) was published by Morris in 1953 who examined the incidence of coronary artery disease
(CAD) in London bus driver teams.
• He clearly documented that the incidence of CAD was less in the middle-age conductors than
in the sedentary drivers of the same age.
• Subsequently, studies in more than 100 000 individuals clearly documented that the higher the
level of physical fitness, the less likely an individual will suffer premature cardiovascular death
(reviewed in Lee et al.2).
• Based on these studies, all major cardiovascular societies made physical activity part of their
guidelines for prevention of CVD (class I recommendation), recommending at least 30 min of
moderate-intensity aerobic activity, 7 days per week with a minimum of 5 days per week
Results in primary cardiovascular disease prevention: dose–response
• Many older studies dichotomized participants into physically active vs. inactive groups, more
recent studies have grouped the participants into multiple quantitatively designated categories
of physical activity (such as quartiles of leisure-time physical activity), making it possible to
assess a dose–response relation between physical activity and mortality.
• As a result, inverse dose–response relations have been found between volume of physical
activity behaviour and all-cause mortality,CVD mortalityand risk of CAD.
• Notably, Wen et al.and Sattelmair et al have reported that even 15 min of daily exercise (about
half of the minimal level of guideline recommendation13) is associated with a significant
reduction of all-cause mortality or CAD risk.
• This finding may support the guideline's assertion that some physical activity is better than
none.This is also evident in the study by Myers, where moving from the worst to the second
worst quintile provided the largest benefit
Prevention of cardiovascular disease in diabetes and obese population
• Most deaths due to diabetes are attributable to CVD, especially CAD. Previous data strongly
support the role of lifestyle intervention involving physical activity to improve glucose and
insulin homeostasis and CVD risk factors.The Diabetes Prevention Program Research
Group demonstrated that a lifestyle modification program with goals of ≥7% weight loss and
≥150 min/week of physical activity in overweight patients with impaired fasting glucose
resulted in a 58% reduction in the incidence of diabetes mellitus, whereas there was a 31%
reduction with metformin (850 mg twice daily) compared with placebo.
• Tanasescu et al.reported in their 14-year follow-up study that the total amount of physical
activity was inversely related with all-cause mortality in diabetic men. Intriguingly, in their
study, walking pace was inversely associated with CVD, fatal CVD, and all-cause mortality,
independent of walking hours. On the basis of these findings, the 2009 AHA Scientific
Statement on ET in type 2 diabetes mellitus recommends 150 min/week of moderate-
intensity exercise combined with resistance training
• Although weight loss is important in obese patients, current exercise protocols in
cardiac rehabilitation (CR) result in little weight loss, in part because of the low
energy expenditure of 700–800 kcal/week. In a randomized controlled clinical trial.
• comparing the effect of high-calorie-expenditure exercise (3000–3500 kcal/week
exercise-related energy expenditure) with standard exercise (700–800 kcal/week)
on weight loss and risk factors, 5 months, high-calorie-expenditure exercise resulted
in greater weight loss (−8.2 vs. −3.7 kg, P < 0.001) and more favourable CVD risk
profiles than standard exercise.
• In addition, Blair and colleagues reported that in men with documented or suspected
coronary heart disease, cardiorespiratory fitness greatly modifies the relation of
adiposity and mortality
• Several observational studies have been published regarding the relation between participation
in a CR program and the CV prognosis in post-myocardial infarction, post-coronary intervention,
and elderly CAD patients Witt et al. reported that participation in CR was independently
associated with decreased mortality and recurrent MI, and that its protective effect was stronger
in more recent years. In another study, the relation between the number of CR sessions attended
and mortality/MI risk at 4 years in elderly CAD patients was analysed.27 An inverse dose–response
relation between session attendance and mortality/MI risk was observed at 4 years. Likewise, in
a prospective cohort study in Canada, Martin et al.reported that, compared with non-completers
(n = 554), CR completers (n = 2900) had a lower risk of death (adjusted hazard ratio 0.59), all-
cause hospitalization (adjusted hazard ratio, 0.77), and cardiac hospitalization (adjusted hazard
ratio 0.68).
• Suaya et al. performed extensive analyses to control for potential confounding between CR
users and non-users among 600 000 Medicare CAD patients (age ≥65 years), and found that 5-
year mortality rates were 21–34% lower in the CR users than non-users.
• There have been prospective randomized trials of ET in other aspects of CVD
prevention. Hambrecht et al.34 as well as Niebauer et al.35 have demonstrated
that long-term ET can halt the progression and, in some cases, actually
promote regression of coronary atherosclerotic lesions . Additionally, in the
ETICA trial,36 the ET group showed a significantly better cardiac event-free
survival than the non-exercise group in patients after PCI with balloon
angioplasty or bare-metal stents at 33-month follow-up. Furthermore,
Hambrecht et al.37 compared ET vs. PCI with bare-metal stents in patients with
stable angina pectoris, and found that ET improved event-free survival at 12-
month follow-up.
secondary cardiovascular disease prevention: meta-analysis and guidelines
• Since modern comprehensive CR programs contain not only ET but also patient education
and counselling, it is difficult to see how much effect is attributable to exercise per se. In
the meta-analysis of 2004, Taylor et al.31 reported that the effect size of total mortality
reduction was not significantly different between exercise-only CR and comprehensive CR
(−24 vs. −16%, NS).
• In a subsequent meta-analysis,38 they estimated that approximately half of the 28%
reduction in cardiac mortality achieved with exercise-based CR was attributable to
reductions in major risk factors, and hence, the remaining half attributable to exercise per
se. Taken together, it is clear that ET/physical activity reduces CVD/CAD risk in addition to
dietary and/or pharmacological interventions in primary and secondary prevention. In
relation to this, both European and American guidelines for CVD prevention5,12 describe
recommendations for physical activity and CR participation in independent sections
Molecular mechanisms
Endothelial function and nitric oxide bioavailability
• One of the most important molecular consequences of regular physical exercise is the absolute
increase of vascular nitric oxide (NO) concentration. NO is responsible for vasodilation, which
results in the lowering of peripheral resistance and increase of perfusion. Endothelial nitric oxide
synthase (eNOS), the main source of NO, is up-regulated by an increase in flow-mediated shear
stress associated with physical exercise due to a complex pattern of intracellular regulation like
acetylation,51 phosphorylation,52 and translocation to the caveolae.53 Numerous investigations have
now clearly documented that exercise or increased shear stress up-regulates eNOS activity
either in cell culture,54 animal,55 or human studies.56 Nevertheless, it remains unclear how an
elevated shear stress is translated into increased eNOS activity. On the luminal side of the
endothelial cells, direct signalling can occur through deformation of the glycocalyx which results
in the activation of calcium ion channels, phospholipase activity leading to calcium signalling,
PGI2-release, and cAMP-mediated smooth-muscle-cell relaxation.57 In addition, VEGFR2 is
located at the luminal surface and can associate with VE-cadherin, β-catenin, and
phosphatidylinositol 3 kinase to phosphorylate Akt and induce AKT-mediated eNOS
phosphorylation, leading to higher NO production
 Exercise as prevention in CAD
CENTER FOR PHYSIOTHERAPY AND REHABILITATION
SCIENCE
JAMIA MILLIA ISLAMIA
Tobacco control to fight physical inactivity
• Control of tobacco consumption has been impressively successful despite deep-rooted addiction in many
countries. Warning labels, tax increases, and smoke-free places resulted in elimination of tobacco
consumption from many areas of public life. Figure 6 shows the change in cigarettes consumption and
prevalence of smoking in youths during a period of nearly 20 years in Germany. Although no single
intervention was effective by itself, the combination of several tax hikes, smoking ban in public areas,
warning signs, and restriction of tobacco sales to youths caused a highly significant downturn of cigarette
consumption by nearly 50% (Figure 6). Can this experience therefore serve as a template for fighting
physical inactivity? Probably not but there are some parallels: tobacco consumption and physical inactivity
are major risk factors for CAD; both of them are difficult to fight and there is no pill as is the case for the
treatment of hypercholesterolaemia or hypertension. But there are also major differences: tobacco
consumption is susceptible to powerful negative incentives such as the taxation and a ban in public areas,
transportation, and restaurants. To increase physical activity, positive incentives would be required, but
presently they are weak or missing altogether. There are numerous aspects how improvements could be
implemented without major changes in existing regulations or great investments: membership fees for gyms
and sports clubs as well as sports equipment could be made tax deductible. Physical activity could be
encouraged by establishing safer cycling routes especially for school children, to promote walking as a
means of at least partial daily transportation
 Exercise as prevention in CAD
• In conclusion, physical activity is one of the most fundamental factors
necessary for maintaining health and warding-off risk factors; long-term
compliance, however, is poor in the vast majority of patients. Until today, all
strategies to improve adherence significantly have failed and long-term trends
seem to point the wrong direction. New concepts need to be contemplated,
borrowing from successful fights against other risk factors.
 Exercise as prevention in CAD
 Exercise as prevention in CAD
Refrences
1
Morris J, Heady JA, Raffle PAB, Roberts CG, Parks JW. Coronary artery disease and physical activity of work, Lancet, 1953, vol. 265 (pg. 1053-1057)10.1016/S0140-6736(53)90665-5
Google ScholarCrossrefPubMed
2
Lee DC, Artero EG, Xuemei S, Blair SN. Review: mortality trends in the general population: the importance of cardiorespiratory fitness, J Psychopharmacol, 2010, vol. 24 (pg. 27-35)10.1177/1359786810382057
Google ScholarCrossrefPubMed
3
Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, Thompson PD, Bauman A. Physical activity and public health: updated recommendation for adults from the American College of
Sports Medicine and the American Heart Association, Circulation, 2007, vol. 116 (pg. 1081-1093)10.1161/CIRCULATIONAHA.107.185649
Google ScholarCrossrefPubMed
4
Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner
Z, Ruilope L, Sans-Menendez S, Scholte op Reimer WJ, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein
K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Hellemans I, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli
S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokg+Âzoglu L, Wiklund O, Zampelas
A. European guidelines on cardiovascular disease prevention in clinical practice: executive summary, Eur Heart J, 2007, vol. 28 (pg. 2375-2414)10.1093/eurheartj/ehm316
Google ScholarCrossrefPubMed
5
Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, Gibbons RJ, Grundy SM, Hiratzka LF, Jones DW, Lloyd-Jones DM, Minissian M, Mosca L, Peterson ED, Sacco RL, Spertus J, Stein
JH, Taubert KA. AHA/ACCF secondary prevention and risk reduction therapy for patients with co
5
Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, Gibbons RJ, Grundy SM, Hiratzka LF, Jones DW, Lloyd-Jones DM, Minissian M, Mosca L, Peterson ED, Sacco RL, Spertus J, Stein JH, Taubert KA. AHA/ACCF secondary prevention and risk
reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update, Circulation, 2011, vol. 124 (pg. 2458-2473)10.1161/CIR.0b013e318235eb4d
Google ScholarCrossrefPubMed
6
Proper KI, Singh AS, van Mechelen W, Chinapaw MJM. Sedentary behaviors and health outcomes among adults: a systematic review of prospective studies, Am J Prev Med, 2011, vol. 40 (pg. 174-182)10.1016/j.amepre.2010.10.015
Google ScholarCrossrefPubMed
7
Katzmarzyk PT, Lee IM. Sedentary behaviour and life expectancy in the USA: a cause-deleted life table analysis, BMJ Open, 2012, vol. 2 pg. e000828 10.1136/bmjopen-2012-000828
Google ScholarCrossrefPubMed
8
Wei M, Kampert JB, Barlow CE, Nichaman MZ, Gibbons LW, Paffenbarger RS, Blair SN. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men, JAMA, 1999, vol. 282 (pg. 1547-1553)10.1001/jama.282.16.1547
Google ScholarCrossrefPubMed
9
Nocon M, Hiemann T, Müller-Riemenschneider F, Thalau F, Roll S, Willich SN. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis, Eur J Cardiovasc Prev Rehabil, 2008, vol. 15 (pg. 239-
246)10.1097/HJR.0b013e3282f55e09
Google ScholarCrossrefPubMed
10
Kodama S. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis, JAMA, 2009, vol. 301 (pg. 2024-2035)10.1001/jama.2009.681
Google ScholarCrossrefPubMed
11
Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing, N Engl J Med, 2002, vol. 346 (pg. 793-801)10.1056/NEJMoa011858
Vanuzzo D, Viigimaa M, Volpe M, Wiklund O, Wolpert C. Other experts who contributed to parts of the guidelinesEuropean Guidelines on cardiovascular disease prevention in clinical practice (version 2012), Eur Heart J, 2012, vol. 33 (pg. 1635-1701) ESC Committee for
Practice Guidelines (CPG) Document Review 10.1093/eurheartj/ehs092
Google ScholarCrossrefPubMed
13
Redberg RF, Benjamin EJ, Bittner V, Braun LT, Goff DCJr, Havas S, Labarthe DR, Limacher MC, Lloyd-Jones DM, Mora S, Pearson TA, Radford MJ, Smetana GW, Spertus JA, Swegler EW. ACCF/AHA 2009 Performance measures for primary prevention of
cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on performance measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) Developed
in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association Endorsed by the American College of Preventive Medicine, American College of Sports
Medicine, and Society for Women's Health Research, J Am Coll Cardiol, 2009, vol. 54 (pg. 1364-1405)10.1016/j.jacc.2009.08.005
Google ScholarCrossrefPubMed
14
Lee IM, Skerrett PJ. Physical activity and all-cause mortality: what is the dose-response relation?, Med Sci Sports Exerc, 2001, vol. 33 (pg. S459-S471)10.1097/00005768-200106001-00016
Google ScholarCrossrefPubMed
15
Wen CP, Wai JP, Tsai MK, Yang YC, Cheng TY, Lee MC, Chan HT, Tsao CK, Tsai SP, Wu X. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study, Lancet, 2011, vol. 378 (pg. 1244-1253)10.1016/S0140-
6736(11)60749-6
Google ScholarCrossrefPubMed
16
Shiroma EJ, Lee IM. Physical activity and cardiovascular health, Circulation, 2010, vol. 122 (pg. 743-752)10.1161/CIRCULATIONAHA.109.914721
Google ScholarCrossrefPubMed
17
Sattelmair J, Pertman J, Ding EL, Kohl HW, Haskell W, Lee IM. Dose response between physical activity and risk of coronary heart disease / clinical perspective, Circulation, 2011, vol. 124 (pg. 789-795)10.1161/CIRCULATIONAHA.110.010710
Google ScholarCrossrefPubMed
18
Wagner A, Simon C, Evans A, Ferrieres J, Montaye M, Ducimetiere P, Arveiler D. on behalf of

More Related Content

PDF
Circulation
PPTX
Journal club
PDF
Sedentary Behaviors Increase Risk of Cardiovascular Disease Mortality In Men
PPTX
Seminar presentation 8
PDF
Normal-Weight Obesity & Risk of Subclinical Atherosclerosis
PPT
Cilostazol treatment intermittent claudication
PDF
Intermittent claudication
PPT
Primary Prevention of Cardiovascular Disease: The Role of Aspirin and Statins
Circulation
Journal club
Sedentary Behaviors Increase Risk of Cardiovascular Disease Mortality In Men
Seminar presentation 8
Normal-Weight Obesity & Risk of Subclinical Atherosclerosis
Cilostazol treatment intermittent claudication
Intermittent claudication
Primary Prevention of Cardiovascular Disease: The Role of Aspirin and Statins

What's hot (19)

PPTX
Effects of aspirin for primary prevention in persons with Diabetes mellitus
PPTX
3. muscular strength and cardiovascular disease
PPTX
Seminar presentation 3
PDF
Effetti degli integratori di calcio sul rischio di infarto del miocardio e di...
PPTX
Aspirin as Prevention Therapy for Cardiovascular Events in patients with Diab...
PPTX
Exercise as an intervention to reduce blood lipids and choloesterol levels
PPTX
Aspirin use for the primary prevention of cardiovascular disease and colorect...
PDF
2016 hope 3 cognitive outcomes slides
PDF
Abcc3
PDF
Abcc4
DOCX
Current trends in cardiovascular assessment
PDF
Relative Hyperoxia in cyanotic congenital heart disease on veno-arterial ECMO...
PDF
Cardiorespiratory Fitness, Health Outcomes, and Health Care Costs: The Case f...
PPTX
Aspirin for primary prevention of CVD
PDF
Postprandial hypertriglyceridemia and androgen dysfunction
PPTX
Calcium and Hypertension
PDF
OSTEOARTHRITIS IN POSTMENOPAUSAL WOMEN
PPT
The Use of Aspirin for Primary Prevention of Cardiovascular Diseases - Dr. Mu...
PPTX
Aspirin for primary prevention in cad in type II DM
Effects of aspirin for primary prevention in persons with Diabetes mellitus
3. muscular strength and cardiovascular disease
Seminar presentation 3
Effetti degli integratori di calcio sul rischio di infarto del miocardio e di...
Aspirin as Prevention Therapy for Cardiovascular Events in patients with Diab...
Exercise as an intervention to reduce blood lipids and choloesterol levels
Aspirin use for the primary prevention of cardiovascular disease and colorect...
2016 hope 3 cognitive outcomes slides
Abcc3
Abcc4
Current trends in cardiovascular assessment
Relative Hyperoxia in cyanotic congenital heart disease on veno-arterial ECMO...
Cardiorespiratory Fitness, Health Outcomes, and Health Care Costs: The Case f...
Aspirin for primary prevention of CVD
Postprandial hypertriglyceridemia and androgen dysfunction
Calcium and Hypertension
OSTEOARTHRITIS IN POSTMENOPAUSAL WOMEN
The Use of Aspirin for Primary Prevention of Cardiovascular Diseases - Dr. Mu...
Aspirin for primary prevention in cad in type II DM
Ad

Similar to Exercise as prevention in CAD (20)

PPTX
Exercise as a prescriptive medicine in Non Communicable Diseases
PDF
Fitness and health
PDF
Cardiovascular Diseases and Physical Education
PPT
The role of exercise in medicine
PPT
Impact Of Cardiovascular Health On Youthful Aging2
PPTX
Lifestyle disease and its primary and secondary prevention
PPT
Coronary Heart Disease and Exercise: What's the evidence?
PPTX
PPT
Exercise Treatment Of The Obese Patient
PPTX
Myths and legacy of exercisemedicine in chronic diseases
PDF
exerciseinolderadults-130630204955-phpapp01 (2).pdf
PPTX
Exercise in Older Adults
PPTX
Cardiac rehabitalization ppt
PPTX
Behavior Modification for Cardiovascular risk factor reduction
PPTX
The Role Of Nutritional Therapies In The Care
PPTX
The Role Of Nutritional Therapies In The Care
PPTX
presentation final draft
PPT
Cardiac rehabilitation
PPT
Physical activity
PDF
Simovska Vera: WoW Europe_Workshop_2021, Health through sport_Romania
Exercise as a prescriptive medicine in Non Communicable Diseases
Fitness and health
Cardiovascular Diseases and Physical Education
The role of exercise in medicine
Impact Of Cardiovascular Health On Youthful Aging2
Lifestyle disease and its primary and secondary prevention
Coronary Heart Disease and Exercise: What's the evidence?
Exercise Treatment Of The Obese Patient
Myths and legacy of exercisemedicine in chronic diseases
exerciseinolderadults-130630204955-phpapp01 (2).pdf
Exercise in Older Adults
Cardiac rehabitalization ppt
Behavior Modification for Cardiovascular risk factor reduction
The Role Of Nutritional Therapies In The Care
The Role Of Nutritional Therapies In The Care
presentation final draft
Cardiac rehabilitation
Physical activity
Simovska Vera: WoW Europe_Workshop_2021, Health through sport_Romania
Ad

More from QuratBenu1 (7)

PPTX
Emotinal factors and exercise an overview
PPTX
Ppt cardiovascular diseses some basic concepts 2
PPTX
Special consideration in cardiac rehabilitation in heart failure patients
PPTX
Respiratory failure and pt 14 oct ppt x
PPTX
Progression of exercise in cardiac rehab pptx
PPTX
Role of cardiopulmonary physiotherapy in covid 19 pptx
PPTX
Phase 1of cardiac rehabilitation ppt x
Emotinal factors and exercise an overview
Ppt cardiovascular diseses some basic concepts 2
Special consideration in cardiac rehabilitation in heart failure patients
Respiratory failure and pt 14 oct ppt x
Progression of exercise in cardiac rehab pptx
Role of cardiopulmonary physiotherapy in covid 19 pptx
Phase 1of cardiac rehabilitation ppt x

Recently uploaded (20)

PPTX
obstructive neonatal jaundice.pptx yes it is
PPTX
vertigo topics for undergraduate ,mbbs/md/fcps
PPTX
ANATOMY OF MEDULLA OBLANGATA AND SYNDROMES.pptx
DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
PPTX
surgery guide for USMLE step 2-part 1.pptx
PPT
MENTAL HEALTH - NOTES.ppt for nursing students
PPTX
1. Basic chemist of Biomolecule (1).pptx
PPTX
MANAGEMENT SNAKE BITE IN THE TROPICALS.pptx
PPTX
2 neonat neotnatology dr hussein neonatologist
PPTX
antibiotics rational use of antibiotics.pptx
PPT
Infections Member of Royal College of Physicians.ppt
PPTX
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
PPTX
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
PDF
TISSUE LECTURE (anatomy and physiology )
PDF
Extended-Expanded-role-of-Nurses.pdf is a key for student Nurses
PPTX
Post Op complications in general surgery
PPT
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
PPTX
Acid Base Disorders educational power point.pptx
PPT
nephrology MRCP - Member of Royal College of Physicians ppt
PPTX
NASO ALVEOLAR MOULDNIG IN CLEFT LIP AND PALATE PATIENT
obstructive neonatal jaundice.pptx yes it is
vertigo topics for undergraduate ,mbbs/md/fcps
ANATOMY OF MEDULLA OBLANGATA AND SYNDROMES.pptx
PEADIATRICS NOTES.docx lecture notes for medical students
surgery guide for USMLE step 2-part 1.pptx
MENTAL HEALTH - NOTES.ppt for nursing students
1. Basic chemist of Biomolecule (1).pptx
MANAGEMENT SNAKE BITE IN THE TROPICALS.pptx
2 neonat neotnatology dr hussein neonatologist
antibiotics rational use of antibiotics.pptx
Infections Member of Royal College of Physicians.ppt
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
TISSUE LECTURE (anatomy and physiology )
Extended-Expanded-role-of-Nurses.pdf is a key for student Nurses
Post Op complications in general surgery
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
Acid Base Disorders educational power point.pptx
nephrology MRCP - Member of Royal College of Physicians ppt
NASO ALVEOLAR MOULDNIG IN CLEFT LIP AND PALATE PATIENT

Exercise as prevention in CAD

  • 1. CENTER FOR PHYSIOTHERAPY AND REHABILITATION SCIENCE JAMIA MILLIA ISLAMIA By Qurat ul aein 19mpc005 MPTcardiorespiratory
  • 2. Exercise in primary prevention of coronary arteries disease
  • 3. • The first scientific evidence regarding the beneficial effects of work associated exercise training (ET) was published by Morris in 1953 who examined the incidence of coronary artery disease (CAD) in London bus driver teams. • He clearly documented that the incidence of CAD was less in the middle-age conductors than in the sedentary drivers of the same age. • Subsequently, studies in more than 100 000 individuals clearly documented that the higher the level of physical fitness, the less likely an individual will suffer premature cardiovascular death (reviewed in Lee et al.2). • Based on these studies, all major cardiovascular societies made physical activity part of their guidelines for prevention of CVD (class I recommendation), recommending at least 30 min of moderate-intensity aerobic activity, 7 days per week with a minimum of 5 days per week
  • 4. Results in primary cardiovascular disease prevention: dose–response • Many older studies dichotomized participants into physically active vs. inactive groups, more recent studies have grouped the participants into multiple quantitatively designated categories of physical activity (such as quartiles of leisure-time physical activity), making it possible to assess a dose–response relation between physical activity and mortality. • As a result, inverse dose–response relations have been found between volume of physical activity behaviour and all-cause mortality,CVD mortalityand risk of CAD. • Notably, Wen et al.and Sattelmair et al have reported that even 15 min of daily exercise (about half of the minimal level of guideline recommendation13) is associated with a significant reduction of all-cause mortality or CAD risk. • This finding may support the guideline's assertion that some physical activity is better than none.This is also evident in the study by Myers, where moving from the worst to the second worst quintile provided the largest benefit
  • 5. Prevention of cardiovascular disease in diabetes and obese population • Most deaths due to diabetes are attributable to CVD, especially CAD. Previous data strongly support the role of lifestyle intervention involving physical activity to improve glucose and insulin homeostasis and CVD risk factors.The Diabetes Prevention Program Research Group demonstrated that a lifestyle modification program with goals of ≥7% weight loss and ≥150 min/week of physical activity in overweight patients with impaired fasting glucose resulted in a 58% reduction in the incidence of diabetes mellitus, whereas there was a 31% reduction with metformin (850 mg twice daily) compared with placebo. • Tanasescu et al.reported in their 14-year follow-up study that the total amount of physical activity was inversely related with all-cause mortality in diabetic men. Intriguingly, in their study, walking pace was inversely associated with CVD, fatal CVD, and all-cause mortality, independent of walking hours. On the basis of these findings, the 2009 AHA Scientific Statement on ET in type 2 diabetes mellitus recommends 150 min/week of moderate- intensity exercise combined with resistance training
  • 6. • Although weight loss is important in obese patients, current exercise protocols in cardiac rehabilitation (CR) result in little weight loss, in part because of the low energy expenditure of 700–800 kcal/week. In a randomized controlled clinical trial. • comparing the effect of high-calorie-expenditure exercise (3000–3500 kcal/week exercise-related energy expenditure) with standard exercise (700–800 kcal/week) on weight loss and risk factors, 5 months, high-calorie-expenditure exercise resulted in greater weight loss (−8.2 vs. −3.7 kg, P < 0.001) and more favourable CVD risk profiles than standard exercise. • In addition, Blair and colleagues reported that in men with documented or suspected coronary heart disease, cardiorespiratory fitness greatly modifies the relation of adiposity and mortality
  • 7. • Several observational studies have been published regarding the relation between participation in a CR program and the CV prognosis in post-myocardial infarction, post-coronary intervention, and elderly CAD patients Witt et al. reported that participation in CR was independently associated with decreased mortality and recurrent MI, and that its protective effect was stronger in more recent years. In another study, the relation between the number of CR sessions attended and mortality/MI risk at 4 years in elderly CAD patients was analysed.27 An inverse dose–response relation between session attendance and mortality/MI risk was observed at 4 years. Likewise, in a prospective cohort study in Canada, Martin et al.reported that, compared with non-completers (n = 554), CR completers (n = 2900) had a lower risk of death (adjusted hazard ratio 0.59), all- cause hospitalization (adjusted hazard ratio, 0.77), and cardiac hospitalization (adjusted hazard ratio 0.68). • Suaya et al. performed extensive analyses to control for potential confounding between CR users and non-users among 600 000 Medicare CAD patients (age ≥65 years), and found that 5- year mortality rates were 21–34% lower in the CR users than non-users.
  • 8. • There have been prospective randomized trials of ET in other aspects of CVD prevention. Hambrecht et al.34 as well as Niebauer et al.35 have demonstrated that long-term ET can halt the progression and, in some cases, actually promote regression of coronary atherosclerotic lesions . Additionally, in the ETICA trial,36 the ET group showed a significantly better cardiac event-free survival than the non-exercise group in patients after PCI with balloon angioplasty or bare-metal stents at 33-month follow-up. Furthermore, Hambrecht et al.37 compared ET vs. PCI with bare-metal stents in patients with stable angina pectoris, and found that ET improved event-free survival at 12- month follow-up.
  • 9. secondary cardiovascular disease prevention: meta-analysis and guidelines • Since modern comprehensive CR programs contain not only ET but also patient education and counselling, it is difficult to see how much effect is attributable to exercise per se. In the meta-analysis of 2004, Taylor et al.31 reported that the effect size of total mortality reduction was not significantly different between exercise-only CR and comprehensive CR (−24 vs. −16%, NS). • In a subsequent meta-analysis,38 they estimated that approximately half of the 28% reduction in cardiac mortality achieved with exercise-based CR was attributable to reductions in major risk factors, and hence, the remaining half attributable to exercise per se. Taken together, it is clear that ET/physical activity reduces CVD/CAD risk in addition to dietary and/or pharmacological interventions in primary and secondary prevention. In relation to this, both European and American guidelines for CVD prevention5,12 describe recommendations for physical activity and CR participation in independent sections
  • 11. Endothelial function and nitric oxide bioavailability • One of the most important molecular consequences of regular physical exercise is the absolute increase of vascular nitric oxide (NO) concentration. NO is responsible for vasodilation, which results in the lowering of peripheral resistance and increase of perfusion. Endothelial nitric oxide synthase (eNOS), the main source of NO, is up-regulated by an increase in flow-mediated shear stress associated with physical exercise due to a complex pattern of intracellular regulation like acetylation,51 phosphorylation,52 and translocation to the caveolae.53 Numerous investigations have now clearly documented that exercise or increased shear stress up-regulates eNOS activity either in cell culture,54 animal,55 or human studies.56 Nevertheless, it remains unclear how an elevated shear stress is translated into increased eNOS activity. On the luminal side of the endothelial cells, direct signalling can occur through deformation of the glycocalyx which results in the activation of calcium ion channels, phospholipase activity leading to calcium signalling, PGI2-release, and cAMP-mediated smooth-muscle-cell relaxation.57 In addition, VEGFR2 is located at the luminal surface and can associate with VE-cadherin, β-catenin, and phosphatidylinositol 3 kinase to phosphorylate Akt and induce AKT-mediated eNOS phosphorylation, leading to higher NO production
  • 13. CENTER FOR PHYSIOTHERAPY AND REHABILITATION SCIENCE JAMIA MILLIA ISLAMIA
  • 14. Tobacco control to fight physical inactivity • Control of tobacco consumption has been impressively successful despite deep-rooted addiction in many countries. Warning labels, tax increases, and smoke-free places resulted in elimination of tobacco consumption from many areas of public life. Figure 6 shows the change in cigarettes consumption and prevalence of smoking in youths during a period of nearly 20 years in Germany. Although no single intervention was effective by itself, the combination of several tax hikes, smoking ban in public areas, warning signs, and restriction of tobacco sales to youths caused a highly significant downturn of cigarette consumption by nearly 50% (Figure 6). Can this experience therefore serve as a template for fighting physical inactivity? Probably not but there are some parallels: tobacco consumption and physical inactivity are major risk factors for CAD; both of them are difficult to fight and there is no pill as is the case for the treatment of hypercholesterolaemia or hypertension. But there are also major differences: tobacco consumption is susceptible to powerful negative incentives such as the taxation and a ban in public areas, transportation, and restaurants. To increase physical activity, positive incentives would be required, but presently they are weak or missing altogether. There are numerous aspects how improvements could be implemented without major changes in existing regulations or great investments: membership fees for gyms and sports clubs as well as sports equipment could be made tax deductible. Physical activity could be encouraged by establishing safer cycling routes especially for school children, to promote walking as a means of at least partial daily transportation
  • 16. • In conclusion, physical activity is one of the most fundamental factors necessary for maintaining health and warding-off risk factors; long-term compliance, however, is poor in the vast majority of patients. Until today, all strategies to improve adherence significantly have failed and long-term trends seem to point the wrong direction. New concepts need to be contemplated, borrowing from successful fights against other risk factors.
  • 19. Refrences 1 Morris J, Heady JA, Raffle PAB, Roberts CG, Parks JW. Coronary artery disease and physical activity of work, Lancet, 1953, vol. 265 (pg. 1053-1057)10.1016/S0140-6736(53)90665-5 Google ScholarCrossrefPubMed 2 Lee DC, Artero EG, Xuemei S, Blair SN. Review: mortality trends in the general population: the importance of cardiorespiratory fitness, J Psychopharmacol, 2010, vol. 24 (pg. 27-35)10.1177/1359786810382057 Google ScholarCrossrefPubMed 3 Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, Thompson PD, Bauman A. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association, Circulation, 2007, vol. 116 (pg. 1081-1093)10.1161/CIRCULATIONAHA.107.185649 Google ScholarCrossrefPubMed 4 Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer WJ, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Hellemans I, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokg+Âzoglu L, Wiklund O, Zampelas A. European guidelines on cardiovascular disease prevention in clinical practice: executive summary, Eur Heart J, 2007, vol. 28 (pg. 2375-2414)10.1093/eurheartj/ehm316 Google ScholarCrossrefPubMed 5 Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, Gibbons RJ, Grundy SM, Hiratzka LF, Jones DW, Lloyd-Jones DM, Minissian M, Mosca L, Peterson ED, Sacco RL, Spertus J, Stein JH, Taubert KA. AHA/ACCF secondary prevention and risk reduction therapy for patients with co
  • 20. 5 Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, Gibbons RJ, Grundy SM, Hiratzka LF, Jones DW, Lloyd-Jones DM, Minissian M, Mosca L, Peterson ED, Sacco RL, Spertus J, Stein JH, Taubert KA. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update, Circulation, 2011, vol. 124 (pg. 2458-2473)10.1161/CIR.0b013e318235eb4d Google ScholarCrossrefPubMed 6 Proper KI, Singh AS, van Mechelen W, Chinapaw MJM. Sedentary behaviors and health outcomes among adults: a systematic review of prospective studies, Am J Prev Med, 2011, vol. 40 (pg. 174-182)10.1016/j.amepre.2010.10.015 Google ScholarCrossrefPubMed 7 Katzmarzyk PT, Lee IM. Sedentary behaviour and life expectancy in the USA: a cause-deleted life table analysis, BMJ Open, 2012, vol. 2 pg. e000828 10.1136/bmjopen-2012-000828 Google ScholarCrossrefPubMed 8 Wei M, Kampert JB, Barlow CE, Nichaman MZ, Gibbons LW, Paffenbarger RS, Blair SN. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men, JAMA, 1999, vol. 282 (pg. 1547-1553)10.1001/jama.282.16.1547 Google ScholarCrossrefPubMed 9 Nocon M, Hiemann T, Müller-Riemenschneider F, Thalau F, Roll S, Willich SN. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis, Eur J Cardiovasc Prev Rehabil, 2008, vol. 15 (pg. 239- 246)10.1097/HJR.0b013e3282f55e09 Google ScholarCrossrefPubMed 10 Kodama S. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis, JAMA, 2009, vol. 301 (pg. 2024-2035)10.1001/jama.2009.681 Google ScholarCrossrefPubMed 11 Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing, N Engl J Med, 2002, vol. 346 (pg. 793-801)10.1056/NEJMoa011858
  • 21. Vanuzzo D, Viigimaa M, Volpe M, Wiklund O, Wolpert C. Other experts who contributed to parts of the guidelinesEuropean Guidelines on cardiovascular disease prevention in clinical practice (version 2012), Eur Heart J, 2012, vol. 33 (pg. 1635-1701) ESC Committee for Practice Guidelines (CPG) Document Review 10.1093/eurheartj/ehs092 Google ScholarCrossrefPubMed 13 Redberg RF, Benjamin EJ, Bittner V, Braun LT, Goff DCJr, Havas S, Labarthe DR, Limacher MC, Lloyd-Jones DM, Mora S, Pearson TA, Radford MJ, Smetana GW, Spertus JA, Swegler EW. ACCF/AHA 2009 Performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on performance measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) Developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association Endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research, J Am Coll Cardiol, 2009, vol. 54 (pg. 1364-1405)10.1016/j.jacc.2009.08.005 Google ScholarCrossrefPubMed 14 Lee IM, Skerrett PJ. Physical activity and all-cause mortality: what is the dose-response relation?, Med Sci Sports Exerc, 2001, vol. 33 (pg. S459-S471)10.1097/00005768-200106001-00016 Google ScholarCrossrefPubMed 15 Wen CP, Wai JP, Tsai MK, Yang YC, Cheng TY, Lee MC, Chan HT, Tsao CK, Tsai SP, Wu X. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study, Lancet, 2011, vol. 378 (pg. 1244-1253)10.1016/S0140- 6736(11)60749-6 Google ScholarCrossrefPubMed 16 Shiroma EJ, Lee IM. Physical activity and cardiovascular health, Circulation, 2010, vol. 122 (pg. 743-752)10.1161/CIRCULATIONAHA.109.914721 Google ScholarCrossrefPubMed 17 Sattelmair J, Pertman J, Ding EL, Kohl HW, Haskell W, Lee IM. Dose response between physical activity and risk of coronary heart disease / clinical perspective, Circulation, 2011, vol. 124 (pg. 789-795)10.1161/CIRCULATIONAHA.110.010710 Google ScholarCrossrefPubMed 18 Wagner A, Simon C, Evans A, Ferrieres J, Montaye M, Ducimetiere P, Arveiler D. on behalf of